Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.66 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 426.6 mg (equivalent: lidocaine hydrochloride, qty 400 mg) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.65 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 20 mg/ml - injection, emulsion - excipient ingredients: sodium oleate; soya oil; egg lecithin; water for injections; glycerol; medium chain triglycerides - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; water for injections; glycerol; medium chain triglycerides; sodium oleate; egg lecithin - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; egg lecithin; medium chain triglycerides; glycerol; sodium oleate; water for injections - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: water for injections; glycerol; medium chain triglycerides; sodium oleate; soya oil; egg lecithin - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.